ÂÜÀòÂÒÂ×

Karin Stebbins has worked in the pharmaceutical industry since 1993. Karin began as a Senior Research Associate Scientist at Ariad Pharmaceuticals, then moved to UCB Research as a Senior Scientist II in 2000. In 2005, they were a Scientist II at Organon Research Center USAS and a Consulting Scientist at Vertex Pharmaceuticals. In 2007, they began working at TargeGen, Inc. as a Scientist. From 2008 to 2011, they were a Senior Scientist and Research Scientist at Amira Pharmaceuticals. From 2011 to 2018, they were an Associate Director and Assistant Director at Inception Sciences, where they were the Head of In vivo Pharmacology and led drug discovery efforts in therapeutic areas such as oncology, fibrosis and neurology. Karin is currently the Director of Pharmacology at Pipeline Therapeutics.

Karin Stebbins attended WLC from 1983 to 1990 and then McGill University from 1989 to 1993, where they obtained a Bachelor of Science in Physiology.